Quantcast

Posts related to ‘Drug companies’

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

Posted: May 18, 2012 at 7:47 am

We are now just about two weeks away from the king of biotech and pharma events in cancer treatments.  The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) ...
Read Full Story »

Dendreon In Trouble

Posted: May 17, 2012 at 11:35 am

Dendreon Corporation (NASDAQ: DNDN) is in trouble.  That is what the performance is telling investors.  The maker of Provenge as a late-stage prostate cancer treatment has three issues working against ...
Read Full Story »

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

Posted: May 10, 2012 at 12:02 pm

It is now getting close to the middle of May, and that means one thing for biotech investors.  The king of biotech and pharma events is about to take place.  ...
Read Full Story »

The Market Where Defensive Shares Are Working Again (PEP, KO, BUD, TAP, AWK, MCD, KFT, CAG, CPB, HRL, MO, VGR, RAI, PG, KMB, CL, MRK, PFE, JNJ, T, VZ)

Posted: May 8, 2012 at 12:07 pm

Blame whatever you want.  A weaker U.S. economy, a weakening and flailing Europe, a move to socialism in France and Greece, a weaker BRIC and emerging market story, commodity prices ...
Read Full Story »

An Earnings Overreaction in PetMed Express? (PETS)

Posted: May 7, 2012 at 1:49 pm

PetMed Express Inc. (NASDAQ: PETS) is far from your usual company.  The company specializes in online drug orders for your pets and it is arguable enough that the company could ...
Read Full Story »

Vertex Sees Billions In Value on Cystic Fibrosis Results (VRTX)

Posted: May 7, 2012 at 8:54 am

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is trading up so much higher that you might think the company is being acquired.  The real reason for the huge share gains is based ...
Read Full Story »

Second Look: Is There Any Real Value Left In Savient? (SVNT, DNDN, SVNT)

Posted: May 2, 2012 at 1:31 pm

Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) already had problems before a fund called Tang Capital accused it of being insolvent this week.  Over the last year this stock has fallen down ...
Read Full Story »

Fast-Acting Erectile Dysfunction Drug Penetrates The Market

Posted: April 28, 2012 at 10:54 am

Men with erectile dysfunction can get relief twice as quickly as was possible in the past. VIVUS, Inc. (NASDAQ: VVUS) received FDA approval for STENDRA (avanafil) tablets. The firm says that ...
Read Full Story »

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

Posted: April 27, 2012 at 9:15 am

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company.  It is one of the biggest public merger rumors out there. At least that is the belief ...
Read Full Story »

J&J Joins Dividend Hike One-Up Game (JNJ, PFE, MRK)

Posted: April 26, 2012 at 11:13 am

How many DJIA components can raise their dividend in one week?  Johnson & Johnson (NYSE: JNJ) answered that question as "Who knows, but we can make it one more!"  J&J ...
Read Full Story »

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Posted: April 23, 2012 at 2:54 pm

Ardea Biosciences, Inc. (NASDAQ: RDEA) is soaring today on news that AstraZeneca PLC (NYSE: AZN) is paying about $1.26 billion to acquire the company.  With another small-cap to mid-cap biotech and ...
Read Full Story »

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Posted: April 23, 2012 at 7:59 am

Diabetes drug maker Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has hired bankers and lawyers to help the company find a buyer. In February Amylin turned down a $3.5 billion ($22/share) offer ...
Read Full Story »

Key Biotech Issues To Watch (XBI, ANIK, BCRX, CBST, DNDN, GILD, ILMN, TRGT)

Posted: April 18, 2012 at 8:23 am

Biotech is a sector which is often mixed with a hodge-podge of winners and losers based on news flow from analysts and/or key drug developments which often have very little to ...
Read Full Story »

VioPharma Runs Into FDA & FTC Troubles Over Staph Drug (VPHM)

Posted: April 10, 2012 at 8:35 am

ViroPharma Incorporated (NASDAQ: VPHM) is getting crushed on news that the Food & Drug Administration has denied the petition filed by ViroPharma on March 17, 2006 related to the FDA's ...
Read Full Story »

VIVUS Faces Shareholder Risks After FDA Delay On Obesity Pill (VVUS, ARNA, OREX)

Posted: April 10, 2012 at 7:11 am

VIVUS Inc. (NASDAQ: VVUS) is getting a bit of a haircut this morning on the heels of some news from the Food & Drug Administration which may throw up some ...
Read Full Story »